174 related articles for article (PubMed ID: 31862185)
1. Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized Prostate Cancer-A Pilot Study.
Fennessy FM; Fedorov A; Vangel MG; Mulkern RV; Tretiakova M; Lis RT; Tempany C; Taplin ME
Acad Radiol; 2020 Oct; 27(10):1432-1439. PubMed ID: 31862185
[TBL] [Abstract][Full Text] [Related]
2. mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy.
Gold SA; VanderWeele DJ; Harmon S; Bloom JB; Karzai F; Hale GR; Marhamati S; Rayn KN; Mehralivand S; Merino MJ; Gulley JL; Bilusic M; Madan RA; Choyke PL; Turkbey B; Dahut W; Pinto PA
Urol Oncol; 2019 Jun; 37(6):352.e25-352.e30. PubMed ID: 31000430
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.
Fedorov A; Vangel MG; Tempany CM; Fennessy FM
Invest Radiol; 2017 Sep; 52(9):538-546. PubMed ID: 28463931
[TBL] [Abstract][Full Text] [Related]
4. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
5. Early change in apparent diffusion coefficient as a predictor of response to neoadjuvant androgen deprivation and external beam radiation therapy for intermediate- to high-risk prostate cancer.
Franco FB; Leeman JE; Fedorov A; Vangel M; Fennessy FM
Clin Radiol; 2024 Apr; 79(4):e607-e615. PubMed ID: 38302377
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
7. Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response.
Karzai F; Walker SM; Wilkinson S; Madan RA; Shih JH; Merino MJ; Harmon SA; VanderWeele DJ; Cordes LM; Carrabba NV; Bright JR; Terrigino NT; Chun G; Bilusic M; Couvillon A; Hankin A; Williams MN; Lis RT; Ye H; Choyke PL; Gulley JL; Sowalsky AG; Turkbey B; Pinto PA; Dahut WL
Clin Cancer Res; 2021 Jan; 27(2):429-437. PubMed ID: 33023952
[TBL] [Abstract][Full Text] [Related]
8. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
[TBL] [Abstract][Full Text] [Related]
9. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
[TBL] [Abstract][Full Text] [Related]
10. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
11. The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI.
Fedorov A; Penzkofer T; Hirsch MS; Flood TA; Vangel MG; Masry P; Tempany CM; Mulkern RV; Fennessy FM
Acad Radiol; 2015 May; 22(5):548-55. PubMed ID: 25683501
[TBL] [Abstract][Full Text] [Related]
12. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
[TBL] [Abstract][Full Text] [Related]
13. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer.
Chatterjee A; Gallan AJ; He D; Fan X; Mustafi D; Yousuf A; Antic T; Karczmar GS; Oto A
Abdom Radiol (NY); 2019 Jun; 44(6):2233-2243. PubMed ID: 30955071
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy.
Giannarini G; Cereser L; Como G; Bonato F; Pizzolitto S; Valotto C; Ficarra V; Dal Moro F; Zuiani C; Girometti R
Acta Radiol; 2021 Jul; 62(7):949-958. PubMed ID: 32718179
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.
Glazer DI; Hassanzadeh E; Fedorov A; Olubiyi OI; Goldberger SS; Penzkofer T; Flood TA; Masry P; Mulkern RV; Hirsch MS; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2017 Mar; 42(3):918-925. PubMed ID: 27770164
[TBL] [Abstract][Full Text] [Related]
16. Detection and localisation of primary prostate cancer using
Kalapara AA; Nzenza T; Pan HYC; Ballok Z; Ramdave S; O'Sullivan R; Ryan A; Cherk M; Hofman MS; Konety BR; Lawrentschuk N; Bolton D; Murphy DG; Grummet JP; Frydenberg M
BJU Int; 2020 Jul; 126(1):83-90. PubMed ID: 31260602
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
[TBL] [Abstract][Full Text] [Related]
18. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
[TBL] [Abstract][Full Text] [Related]
19. Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.
Zanelli E; Giannarini G; Cereser L; Zuiani C; Como G; Pizzolitto S; Crestani A; Valotto C; Ficarra V; Girometti R
J Magn Reson Imaging; 2019 Nov; 50(5):1604-1613. PubMed ID: 30957321
[TBL] [Abstract][Full Text] [Related]
20. A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy.
Orczyk C; Rosenkrantz AB; Deng FM; Melamed J; Babb J; Wysock J; Kheterpal E; Huang WC; Stifelman M; Lepor H; Taneja SS
Urol Oncol; 2016 Jan; 34(1):3.e1-8. PubMed ID: 26338414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
